Wednesday, December 30, 2020

Glenmark Pharma gets USFDA nod for erectile dysfunction treatment drug

Glenmark Pharma gets USFDA nod for erectile dysfunction treatment drug Glenmark Pharmaceuticals Ltd has received final approval from the United States Food and Drug Administration (USFDA) for Tadalafil tablets USP in the strengths of 2.5 mg, 5 mg, 10 mg and 20 mg, the company said in a regulatory filing.

from Moneycontrol Business News https://ift.tt/3hzEsrl
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Asian shares start cautiously, dollar edges down

Asian shares opened cautiously amid anticipation of fresh trade news influencing US asset demand. The dollar weakened as trade tensions and ...